CLINICAL TRIAL SUMMARY

MDACC Study No:RTOG0413 (clinicaltrials.gov NCT No: NCT00103181)
Title:A Randomized Phase III Study of Conventional Breast Irradiation (WBI) versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer
Principal Investigator:Eric A. Strom
Treatment Agent:Radiation
Study Status:Closed
Study Description:The goal of this clinical research study is to see if a 1-week course of
partial breast irradiation is more effective than a 6-week course of whole
breast radiation treatment for keeping cancer from coming back in the breast
while keeping a good cosmetic outcome.

Hide details for General InformationGeneral Information

Disease Group:Breast
Phase of Study:Phase III
Treatment Agents:Radiation
Treatment Location:Independent Multicenter Arrangements
Estimated Length of Stay in Houston:N/A
Supported By:N/A
Return Visit:For the first year, at 4 weeks, 6 months, and 12 months following therapy; then
every 6 months for 4 years, then yearly thereafter.
Home Care:N/A


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Eric A. Strom
Dept:Radiation Oncology
For Clinical Trial Enrollment:713-563-2356
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults